Add-on Acquisition • Life Science

Acerus Pharma Acquires Serenity

On February 28, 2022, Acerus Pharma acquired life science company Serenity for 6M USD

Acquisition Context

This is Acerus Pharma’s 1st transaction in the Life Science sector.
This is Acerus Pharma’s largest (disclosed) transaction.
This is Acerus Pharma’s 1st transaction in the United States.
This is Acerus Pharma’s 1st transaction in Pennsylvania.

Explore All 3116 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	February 28, 2022
Target	Serenity
Sector	Life Science
Buyer(s)	Acerus Pharma
Deal Type	Add-on Acquisition
Deal Value	6M USD

Target Company

Serenity

Milford, Pennsylvania, United States

Serenity is a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders. Serenity is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective treatments for voiding disorders. Serenity was founded in 2006 and is based in Milford, Pennsylvania.

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Acerus Pharma

Mississauga, Ontario, Canada

Category	Company
Founded	2008
Sector	Life Science
Employees	10
Revenue	1M CAD (2020)

DESCRIPTION

Acerus Pharma is a specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus on the field of men’s health. Acerus Pharma commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories. Acerus Pharma was founded in 2008 and is based in Mississauga, Ontario.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Pennsylvania	1 of 1
Country: United States	1 of 1
Year: 2022	1 of 1
Size (of disclosed)	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Pennsylvania M&A - United States M&A - 2022 M&A